Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6866940 | 1.00 | PTGDR (0.74) | PTGDRTBXA2R | |
| SCHEMBL6866936 | 1.00 | PTGDR (0.74) | PTGDRTBXA2R | |
| SCHEMBL7115968 | 0.86 | PTGDR (0.67) | PTGDRTBXA2R | |
| SCHEMBL7115977 | 0.86 | PTGDR (0.67) | PTGDRTBXA2R | |
| SCHEMBL7115973 | 0.86 | PTGDR (0.67) | PTGDRTBXA2R | |
| SCHEMBL7114327 | 0.86 | PTGDR (0.67) | PTGDRTBXA2R | |
| SCHEMBL633588 | 0.85 | PTGDR (1.00) | PTGDRTBXA2R | |
| SCHEMBL6150895 | 0.85 | PTGDR (1.00) | PTGDRTBXA2R | |
| SCHEMBL6935578 | 0.85 | PTGDR (1.00) | PTGDRTBXA2R | |
| SCHEMBL6936201 | 0.85 | PTGDR (1.00) | PTGDRTBXA2R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2912458-B1 | NON-INVASIVE BIOMARKER TO IDENTIFY SUBJECTS AT RISK OF PRETERM DELIVERY | NYU WINTHROP HOSPITAL (US) | 2018-07-18 | — | — | EP | claimed |
| US-9797903-B2 | Non-invasive biomarker to identify subject at risk of preterm delivery | WINTHROP-UNIVERSITY HOSPITAL (US) | 2017-10-24 | — | — | US | claimed |
| US-20150285800-A1 | NON-INVASIVE BIOMARKER TO IDENTIFY SUBJECT AT RISK OF PRETERM DELIVERY | NYU WINTHROP HOSPITAL | 2015-10-08 | — | — | US | claimed |
| US-10408838-B2 | Non-invasive biomarker to identify subject at risk of preterm delivery | NYU WINTHROP HOSPITAL (US) | 2019-09-10 | — | — | US | disclosed |
| EP-3382391-A1 | NON-INVASIVE BIOMARKER TO IDENTIFY SUBJECTS AT RISK OF PRETERM DELIVERY | NYU Winthrop Hospital (US) | 2018-10-03 | — | — | EP | disclosed |
| EP-2912458-B1 | NON-INVASIVE BIOMARKER TO IDENTIFY SUBJECTS AT RISK OF PRETERM DELIVERY | NYU WINTHROP HOSPITAL (US) | 2018-07-18 | — | — | EP | disclosed |
| US-20180003713-A1 | NON-INVASIVE BIOMARKER TO IDENTIFY SUBJECT AT RISK OF PRETERM DELIVERY | WINTHROP-UNIVERSITY HOSPITAL | 2018-01-04 | — | — | US | disclosed |
| US-9797903-B2 | Non-invasive biomarker to identify subject at risk of preterm delivery | WINTHROP-UNIVERSITY HOSPITAL (US) | 2017-10-24 | — | — | US | disclosed |
| US-20150285800-A1 | NON-INVASIVE BIOMARKER TO IDENTIFY SUBJECT AT RISK OF PRETERM DELIVERY | NYU WINTHROP HOSPITAL | 2015-10-08 | — | — | US | disclosed |
| EP-1193243-B1 | NOVEL PROCESS FOR PRODUCING BICYCLIC AMINO ALCOHOL | SHIONOGI & CO (JP) | 2008-08-13 | — | — | EP | disclosed |
| EP-1808427-A2 | Novel processes for the preparation of bicyclic aminoalcohols | SHIONOGI & CO., LTD. (JP) | 2007-07-18 | — | — | EP | disclosed |
| US-20020115871-A1 | Process for preparing benzothiophenecarboxamide derivatives | OKADA TETSUO (JP) | 2002-08-22 | — | — | US | disclosed |
| US-6399788-B1 | AMIDATION | SHIONOGI & CO., LTD. (JP) | 2002-06-04 | — | — | US | disclosed |
| EP-1193243-A1 | NOVEL PROCESS FOR PRODUCING BICYCLIC AMINO ALCOHOL | SHIONOGI & CO., LTD. (JP) | 2002-04-03 | — | — | EP | disclosed |
| US-20020026061-A1 | Process for preparing 5-hydroxybenzo [b] thiophene-3-carboxylic acid derivatives | HONMA TSUNETOSHI (JP) | 2002-02-28 | — | — | US | disclosed |
| US-6346628-B1 | REACTING 4-MERCAPTOPHENOL WITH A PROPARYGL GOUP AND PROTECTION OF HYDROXYL GROUP, OXIDIZING THE PRODUCT, AND THERMAL REARRANGEMENT TO CYCLIZE, FOLLOWED BY FURTHER OXIDATION | SHIONOGI & CO., LTD. (JP) | 2002-02-12 | — | — | US | disclosed |
| US-20020016476-A1 | PROCESS FOR PREPARING 5-HYDROXYBENZO [B] THIOPHENE-3-CARBOXYLIC ACID DERIVATIVES | HONMA TSUNETOSHI (JP) | 2002-02-07 | — | — | US | disclosed |
| US-6320060-B1 | INTRODUCING PROPARGYL GROUP INTO 4-MERCAPTOPHENOL, PROTECTING HYDROXYL GROUP, OXIDIZING COMPOUND, SUBJECTING TO THERMAL REARRANGEMENT REACTION, SUBJECTING TO STEPWISE OXIDATION OF HYDROXYMETHYL GROUP AND OPTIONALLY DEPROTECTION | SHIONOGI & CO., LTD. (JP) | 2001-11-20 | — | — | US | disclosed |
| EP-1069123-A1 | PROCESS FOR PRODUCING BENZOTHIOPHENECARBOXYLIC ACID AMIDE DERIVATIVES | SHIONOGI & CO., LTD. (JP) | 2001-01-17 | — | — | EP | disclosed |
| EP-1069122-A1 | PROCESS FOR PRODUCING 5-HYDROXYBENZO b]THIOPHENE-3-CARBOXYLIC ACID DERIVATIVES | SHIONOGI & CO., LTD. (JP) | 2001-01-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020016476-A1 | PROCESS FOR PREPARING 5-HYDROXYBENZO [B] THIOPHENE-3-CARBOXYLIC ACID DERIVATIVES | HPD, PTGDR2, PTGS2 | PTGDR 4/4885TBXA2R 27/4885 |
| US-20020115871-A1 | Process for preparing benzothiophenecarboxamide derivatives | PGD, HPD, PTGS2 | PTGDR 11/4885TBXA2R 34/4885 |
| US-20020026061-A1 | Process for preparing 5-hydroxybenzo [b] thiophene-3-carboxylic acid derivatives | HPD, PTGDR2, PTGS2 | PTGDR 4/4885TBXA2R 27/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.